Effectively Utilizing Multi-Omics from Early Discovery to Reverse Translation
The Inaugural Multi-Omics Based Drug Discovery & Development Summit 2025 is your uniquely comprehensive scientific forum. We focus on unlocking the full potential of genomics, epigenomics, transcriptomics, proteomics, and metabolomics across drug development and discovery pipelines.
At this event, you'll learn gold-standard omics methodologies and master data harmonization and integration. You can also discover how to apply multi-omics for target identification and precision medicine. Don't miss your opportunity to optimize multi-omics data analysis and generate unique biomedical insights, directly informing therapeutic pipelines.
Key Case Studies From...
Benefits of Attending
Achieve
effective data integration across genomics, epigenomics, transcriptomics, proteomics, metabolomics and beyond to create harmonized, compatible data sets. This will enable you to facilitate comprehensive data analysis and generate unique biological insights, from Poseida Therapeutics & Phenome Health
Navigating
emerging omics technologies, advanced analytical testing, innovative data storage and visualization platforms, and machine learning capabilities. This will help develop a robust multi-omics workflow and expand the scope of multi-omics analysis, with UC San Diego & Resilient Biotics
Unlocking
novel biological insights with efficient translation of large-scale multi-omics data sets into actionable biomedical conclusions to drive informed therapeutic development and exemplify the unique benefit of multi-omic analysis. Lessons from Boehringer Ingelheim & Gilead Sciences
Illuminating
disease mechanisms, signaling pathways and patient response with multi-omics analysis. Deepen your understanding of pathology and disease evolution to better inform therapeutic development. Data-driven case studies from Sanford Burnham Prebys & Boehringer Ingelheim
Unleashing
the potential of multi-omics across drug development pipelines. From target and biomarker identification to patient stratification and reverse translation to revolutionize R&D and clinical development in precision medicine, oncology, immunology, neuroscience, and beyond. Learn more from Multiomic Health & Sinopia Biosciences
Hear From Your Peers
‘I value participating in this meeting because it provides a unique platform to discuss strategic integration of multi-omic approaches for enabling the discovery and development of life-changing medicines’
Senior Scientist
‘This Summit is a valuable opportunity to exchange practical insights on spatial omics workflows, discover emerging best practices, and build collaborations that advance both core operations and translational research. It is a chance to both contribute and learn in a fast-evolving field’
Director, Single-Cell & Spatial Omics Core
